Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 The Multi-Faceted World of Clinical Trial Matching in Precision Oncology Studies By Premier Research September 1, 2023 Medical and Regulatory Affairs Rare Oncology and the FDA: Taking the Guesswork Out of Expedited Pathways By Premier Research June 7, 2023 Clinical ResearchPhase 1 - Phase 4 Beyond Boundaries: Revolutionary CAR-T Therapies Pave Way to Conquer Solid Tumors By Premier Research April 24, 2023 Clinical ResearchPhase 1 - Phase 4 The Rise of Radiotherapeutics: Brief History and Best Practices for Clinical Trials By Premier Research January 5, 2023 Clinical ResearchPhase 1 - Phase 4 Premier Perspective on Biomarkers in Oncology By Premier Research November 2, 2022 Clinical ResearchPhase 1 - Phase 4 Antibody-Drug Conjugates in Oncology: Key Considerations and Future Trends By Premier Research October 13, 2022 Previous 1 2 3 4 … 18 Next × ALSO OF INTERESTUsing the 505(b)(2) Pathway to Streamline...A Fit-for-Purpose Path Forward: Linking RWD to...The Rise of Radiotherapeutics: Brief History...